Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine

Cancer Nanotechnology

Volumn 1, Issue 1-6, 2010, Pages 63-69

  Sun, Zhao ^a   Wang, Wei ^b   Wang, Rui ^c   Duan, Jinhong ^b   Hu, Yan ^b   Ma, Jin ^b   Zhou, Jiayan ^b   Xie, Sishen ^d   Lu, Xin ^a   Zhu, Zhaohui ^a   Chen, Shuchang ^a   Zhao, Yuanli ^e   Xu, Haiyan ^b   Wang, Chen ^c   Yang, Xian Da ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^d INSTITUTE OF PHYSICS   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Aluminum; Anticancer; Immune adjuvant; Nanoparticle

Indexed keywords

ALUMINUM OXIDE; ALUMINUM OXIDE NANOPARTICLE; IMMUNOLOGICAL ADJUVANT; TUMOR CELL VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOTOXICITY; LIVER CELL CARCINOMA; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TUMOR VOLUME;

EID: 79952706913     PISSN: 18686958     EISSN: 18686966     Source Type: Journal    
DOI: 10.1007/s12645-010-0001-5     Document Type: Article

References (29)

1. Berd D, Sato T, Maguire HC Jr, Kairys J, Mastrangelo MJ (2004) Immunopharmacologic analysis of an autologous, hapten- modified human melanoma vaccine. J Clin Oncol 22:403-415
2. Bianco A, Kostarelos K, Partidos CD, Prato M (2005a) Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 5:571-577
3. Bianco A, Kostarelos K, Prato M (2005b) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674-679
4. Cai D, Mataraza JM, Qin ZH, Huang Z, Huang J, Chiles TC, Carnahan D, Kempa K, Ren Z (2005) Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Methods 2:449-454
5. Copier J, Dalgleish A (2006) Overview of tumor cell-based vaccines. Int Rev Immunol 25:297-319
6. Elder JB, Liu CY, Apuzzo ML (2008) Neurosurgery in the realm of 10 (-9), part 2: applications of nanotechnology to neurosurgery- present and future. Neurosurgery 62:269-284, discussion 284-5
7. Emens LA (2006) Roadmap to a better therapeutic tumor vaccine. Int Rev Immunol 25:415-443
8. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 103:6315-6320
9. Fenske DB, Cullis PR (2008) Liposomal nanomedicines. Expert Opin Drug Deliv 5:25-44
10. Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IF, Plebanski M (2004) Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol 173:3148-3154
11. Frey A, Mantis N, Kozlowski PA, Quayle AJ, Bajardi A, Perdomo JJ, Robey FA, Neutra MR (1999) Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles. Vaccine 17:3007-3019
12. Hartman KB, Wilson LJ, Rosenblum MG (2008) Detecting and treating cancer with nanotechnology. Mol Diagn Ther 12:1-14
13. Heller DA, Jeng ES, Yeung TK, Martinez BM, Moll AE, Gastala JB, Strano MS (2006) Optical detection of DNA conformational polymorphism on single-walled carbon nanotubes. Science 311:508-511
14. Jain KK (2008) Nanomedicine: application of nanobiotechnology in medical practice. Med Princ Pract 17:89-101
15. Levy F, Colombetti S (2006) Promises and limitations of murine models in the development of anticancer T-cell vaccines. Int Rev Immunol 25:269-295
16. Lindblad EB (2004) Aluminium adjuvants-in retrospect and prospect. Vaccine 22:3658-3668
17. Liu Y, Wu DC, Zhang WD, Jiang X, He CB, Chung TS, Goh SH, Leong KW (2005) Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Ed Engl 44:4782-4785
18. Luo Y, Wen YJ, Ding ZY, Fu CH, Wu Y, Liu JY, Li Q, He QM, Zhao X, Jiang Y, Li J, Deng HX, Kang B, Mao YQ, Wei YQ (2006) Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2. Clin Cancer Res 12:1813-1819
19. Martin CR, Kohli P (2003) The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2:29-37
20. Mesa C, Fernandez LE (2004) Challenges facing adjuvants for cancer immunotherapy. Immunol Cell Biol 82:644-650
21. Ni Y, Hu H, Malarkey EB, Zhao B, Montana V, Haddon RC, Parpura V (2005) Chemically functionalized water soluble single-walled carbon nanotubes modulate neurite outgrowth. J Nanosci Nano- technol 5:1707-1712
22. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE (1994) Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. Jama 271:907-913
23. Schirrmacher V (2005) Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory. Cancer Immunol Immunother 54:587-598
24. Sun YP, Fu K, Lin Y, Huang W (2002) Functionalized carbon nanotubes: properties and applications. Acc Chem Res 35:1096-1104
25. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356:802-807
26. Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr, Pinedo HM (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353:345-350
27. Williams KA, Veenhuizen PT, de la Torre BG, Eritja R, Dekker C (2002) Nanotechnology: carbon nanotubes with DNA recognition. Nature 420:761
28. Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ (2004) Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64:4973-4979
29. Zanello LP, Zhao B, Hu H, Haddon RC (2006) Bone cell proliferation on carbon nanotubes. Nano Lett 6:562-567